Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Malignant struma ovarii

Abstract

Background A 25-year-old woman presented to her gynecologist with pelvic pain. Pelvic ultrasonography showed a 9 cm left ovarian mass. The patient underwent left oophorectomy, omental biopsy, and lymph node sampling. The ovarian mass proved to be a struma ovarii with numerous microscopic foci of papillary thyroid carcinoma. The patient had no symptoms of hyperthyroidism, and her thyroid function and serum thyroglobulin levels were normal.

Investigations Investigations included a pelvic ultrasound scan, histological examination of the ovarian mass and omental nodules, and lymph node sampling.

Diagnosis Malignant struma ovarii.

Management The patient was referred to an endocrinology clinic for further investigations. Serum levels of TSH, thyroglobulin and thyroglobulin antibodies were measured. In addition, the patient underwent thyroid ultrasonography, which showed a 1 cm nodule that proved benign on biopsy. She was treated with thyroxine to reduce TSH secretion. Follow-up pelvic ultrasonography 1 year later showed no evidence of recurrent disease, and her serum thyroglobulin levels remained normal.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Microscopic focus of papillary thyroid carcinoma, follicular variant, within benign, unremarkable spindled ovarian stroma (hematoxylin and eosin [H & E] staining; magnification ×400).
Figure 2: Benign thyroid tissue (strumosis) present as nodular, circumscribed foci within the omentum (hematoxylin and eosin [H & E] staining; magnification ×100).

References

  1. Medeiros F et al. (2006) Germ cell tumors of the ovary. In: Diagnostic Gynecologic and Obstetric Pathology, 920–921 (eds Crum CP and Lee KR) Philadelphia: Elsevier Saunders

    Google Scholar 

  2. Devaney K et al. (1993) Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 12: 333–343

    Article  CAS  Google Scholar 

  3. Robboy SJ et al. (1995) Prognostic indices in malignant struma ovarii: a clinicopathologic analysis of 36 patients with 20-year follow up. Mod Pathol 8: 95A

    Google Scholar 

  4. Dardik RB et al. (1999) Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol 73: 447–451

    Article  CAS  Google Scholar 

  5. Nakamura N et al. (2006) Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Endocr Pathol 17: 213–223

    Article  CAS  Google Scholar 

  6. Casey MB et al. (2003) Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol 14: 55–60

    Article  Google Scholar 

  7. Schmidt J et al. (2007) BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am J Surg Pathol 31: 1337–1343

    Article  Google Scholar 

  8. Boutross-Tadross O et al. (2007) Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol 18:182–186

    Article  Google Scholar 

  9. Elisei R et al. (2005) RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration. Thyroid 15: 1355–1361

    Article  CAS  Google Scholar 

  10. Brogioni S et al. (2007) A special case of bilateral ovarian metastases in a woman with papillary carcinoma of the thyroid. Exp Clin Endocrinol Diabetes 115: 397–400

    Article  CAS  Google Scholar 

  11. DeSimone CP et al. (2003) Malignant struma ovarii: a case report and analysis of case reported in the literature with focus on survival and I131 therapy. Gynecol Oncol 89: 543–548

    Article  Google Scholar 

  12. Makani S et al. (2004) Struma ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 94: 835–839

    Article  Google Scholar 

  13. Navarro MD et al. (2004) Malignant struma ovarii. Ann Clin Lab Sci 34: 107–112

    PubMed  Google Scholar 

  14. Rose PG et al. (1998) Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels. Gynecol Oncol 70: 425–427

    Article  CAS  Google Scholar 

  15. Rotman-Pikielny P et al. (2000) Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii. J Clin Endocrinol Metab 85: 237–244

    CAS  PubMed  Google Scholar 

  16. Ryder M et al. (2007) Follicular variant papillary thyroid carcinoma arising with an ovarian teratoma. Thyroid 17: 179–180

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ellen Marqusee.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yassa, L., Sadow, P. & Marqusee, E. Malignant struma ovarii. Nat Rev Endocrinol 4, 469–472 (2008). https://doi.org/10.1038/ncpendmet0887

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0887

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing